Acta Neuropathologica Communications

Article	Citations
Clinicopathologic features of two unrelated autopsied patients with Charcot-Marie-Tooth disease carrying MFN2 gene mutation	341
Novel histotypes of sporadic Creutzfeldt–Jakob disease linked to 129MV genotype	173
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation	110
Pleomorphic xanthoastrocytoma in the multiverse of epigenomics: is it time to recognize the variants?	108
Detection of structural DNA variants in medulloblastomas using optical genome mapping	80
Axonal autophagic vesicle transport in the rat optic nerve in vivo under normal conditions and during acute axonal degeneration	75
A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons	71
Fast and slow strains of misfolded mutant superoxide dismutase 1 in familial amyotrophic lateral sclerosis	68
Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxication	61
Correction to: Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas	57
SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature	56
Histomorphological variations in progressive multifocal leukoencephalopathy correlated with JCV replication in brain lesions: insights from 91 patients	56
Correction: Investigating genotype-phenotype correlation of limb-girdle muscular dystrophy R8: association of clinical severity, protein biological function and protein oligomerization	56
Amyloid quantification in the oldest-old: selecting regions for optimizing correspondence between postmortem pathology and amyloid PET	56
NRF2/ARE mediated antioxidant response to glaucoma: role of glia and retinal ganglion cells	55
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI	54
MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value	54
High-grade astrocytoma with piloid features: a single-institution case series and literature review	54
Machine learning quantification of Amyloid-β deposits in the temporal lobe of 131 brain bank cases	53
Alpha-synuclein seeding activity in postmortem tissues from patients with diffuse and isolated Lewy bodies	51
Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study	50
Low-intensity open-field blast exposure effects on neurovascular unit ultrastructure in mice	49
CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway–altered	48
Neutrophil infiltration and microglial shifts in sepsis induced preterm brain injury: pathological insights	47
Single cell protein profiling of focal cortical dysplasia in a patient requiring multiple resections	46

Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination	46
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease	46
Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism	46
DNA methylation as a contributor to dysregulation of STX6 and other frontotemporal Lobar degeneration genetic risk-associated loci	45
Single-cell spatial proteomic imaging for human neuropathology	44
The genomic alterations in glioblastoma influence the levels of CSF metabolites	44
Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer’s-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia	43
Exogenous interleukin 33 enhances the brain’s lymphatic drainage and toxic protein clearance in acute traumatic brain injury mice	43
Early axonal injury in fentanyl intoxication	42
Tau seeding in cases of multiple sclerosis	42
Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data	41
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids	40
4R-tau isoform induction via TDP-43 in neurons in response to insulin: converging signaling pathways with implications for neurodegenerative disease	39
Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis	39
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve	39
ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics	38
Clinical and functional characterization of a long survivor congenital titinopathy patient with a novel metatranscript-only titin variant	38
WFS1 gene delivery rescues visual function in a mouse model of Wolfram syndrome	37
Accurate detection of pathologic α-synuclein in CSF, skin, olfactory mucosa, and urine with a uniform seeding amplification assay	37
Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors	36
Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC), new name and new problems: an illustration of one case with atypical morphology and biology	36
Advancing prion diagnostics: full-length human E200K RT-QuIC substrate facilitates prion detection in tear fluid and improves sensitivity in cerebrospinal fluid	36
Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders	36
Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion	36
Cerebellar granule neurons induce Cyclin D1 before the onset of motor symptoms in Huntington’s disease mice	35
TrkA activation sustains chemotherapy resistance in chemotolerant medulloblastoma cells	34
Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau	34
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease	34
A microdeletion event at 19q13.43 in IDH-mutant astrocytomas is strongly correlated with MYC overexpression	34
A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma	33
Age-dependent interactions of APOE isoform 4 and Alzheimer’s disease neuropathology: findings from the NACC	33
Correction: Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies	32
Differential vulnerability of the dentate gyrus to tauopathies in dementias	32
Clinical and inflammatory factors associated with the extent of resection in primary, sporadic vestibular schwannomas: A retrospective study	32
ROS-regulated SUR1-TRPM4 drives persistent activation of NLRP3 inflammasome in microglia after whole-brain radiation	32
The tumour immune microenvironment is enriched but suppressed in vestibular schwannoma compared to meningioma: therapeutic implications for NF2-related schwannomatosis	31
Single-cell transcriptome sequencing reveals new epithelial-stromal associated mesenchymal-like subsets in recurrent gliomas	31
Facilitated α-synuclein oligomer sharing among glial cells by a centrally acting connexin inhibitor attenuates a rapidly progressive multiple system atrophy-cerebellar type model by reducing the neuro	31
Therapeutic potential of NGF-enriched extracellular vesicles in modulating neuroinflammation and enhancing peripheral nerve remyelination	31
EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma	31
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s	30
CX3CL1/CX3CR1 axis dysregulation contributes to epileptogenic mechanisms in focal cortical dysplasia	30
The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies	29
Establishment of a patient-derived 3D in vitro meningioma model in xeno-free hydrogel for clinical applications	29
A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report	29
MANF protein expression is upregulated in immune cells in the ischemic human brain and systemic recombinant MANF delivery in rat ischemic stroke model demonstrates anti-inflammatory effects	28
Hydrogen peroxide induced by nerve injury promotes axon regeneration via connective tissue growth factor	28
Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangement	28
Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling	28
Correction to: Interplay between androgen and CXCR4 chemokine signaling in myelin repair	28

Systemic IGF-1 administration prevents traumatic brain injury induced gut permeability, dysmorphia, dysbiosis, and the increased number of immature dentate granule cells	27
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration	27
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease	27
Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1C71G ALS mouse model	27
Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration	26
DNA methylation profiling from cerebrospinal fluid as a diagnostic tool for pineoblastoma	26
Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital myasthenic syndrome	26
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma	26
Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei	25
Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis	25
Meningeal-tumor interactions define distinct modes of leptomeningeal colonization in Group 3 medulloblastoma	25
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease	25
Oedematic-atrophic astrocytes in hepatic encephalopathy	25
Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosis	25
Enhancing mitosis quantification and detection in meningiomas with computational digital pathology	25
Immune stimulation recruits a subset of pro-regenerative macrophages to the retina that promotes axonal regrowth of injured neurons	25
Regional vulnerability of brain white matter in vanishing white matter	25
Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration	25
Myelin in Alzheimer’s disease: culprit or bystander?	24
Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis	24
Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations	24
A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin	24
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils	23
Towards a single-assay approach: a combined DNA/RNA sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathology	23
Unveiling the intricate dynamics of the interplay between triple-negative breast cancer cells and the blood-brain barrier endothelium	23
LXR agonist rescues synaptic dysfunction and degeneration in SPG3A patient-specific iPSC-derived neurons	23
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis	23
Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded prote	22
Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas	22
MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma	22
Correction: Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids	22
Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction	22
Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson’s disease	22
APOE-ε4 and BIN1 increase risk of Alzheimer’s disease pathology but not specifically of Lewy body pathology	21
Retraction Note: Decreased neuroinflammation and increased brain energy homeostasis following environmental enrichment after mild traumatic brain injury is associated with improvement in cognitive fun	21
Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B	21
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models	21
Toward a generalizable machine learning workflow for neurodegenerative disease staging with focus on neurofibrillary tangles	21
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation	21
Mass cytometric analysis of the immune cell landscape after traumatic brain injury elucidates the role of complement and complement receptors in neurologic outcomes	20
Repeat length of C9orf72-associated glycine–alanine polypeptides affects their toxicity	20
Intracranial mesenchymal tumor with (novel) COX14::PTEN rearrangement	20
MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy	20
Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model	20
Structural and functional studies of the VAPB-PTPIP51 ER-mitochondria tethering proteins in neurodegenerative diseases	20
Antagonizing Il10 and Il4 signaling via intracerebral decoy receptor expression attenuates Aβ accumulation	20
Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice	20
Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias	20
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice	20
Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment	20
Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors	20
LCN2/SLC22A17 mediates the phagocytosis of GABAergic synapses by oligodendrocyte progenitor cells and contributes to cancer-induced pain and comorbid anxiety-like behaviors in mice	20
Integrated molecular and detailed anatomical profiling identifies a prognostically adverse subtype of posterior fossa meningiomas: high-risk copy number alterations are associated with midline predile	19
Upregulation of carbonic anhydrase 1 beneficial for depressive disorder	19
Retraction Note: Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy	19
Correction: High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy	19
TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord	19
Bridging the gap: investigating the role of phosphorylation at the serine 129 site of α-synuclein in VAPB-PTPIP51 interactions	19
PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective	19
Activated alpha 9 integrin expression enables sensory pathway reconstruction after spinal cord injury	19
H3F3B p.K27I-mutant diffuse midline glioma is a distinct subtype of H3K27-altered diffuse midline glioma	19
Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca2+ and synaptic defects	19
Epitranscriptomic analysis reveals clinical and molecular signatures in glioblastoma	19
Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids	19
Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis	19
Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome	18
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma	18
Blocking peptidyl arginine deiminase 4 confers neuroprotective effect in the post-ischemic brain through both NETosis-dependent and -independent mechanisms	18
Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain	18
Current molecular understanding of central nervous system schwannomas	18
NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors	18
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis	18
TDP43 pathology in chronic traumatic encephalopathy retinas	18
Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)	18
Tumor-like proliferation of CCM3 knockout endothelial cells: insights from semaxinib treatment and transcriptome profiling of co-cultures	18
miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4	18
Spatio-temporal dynamics of microglia phenotype in human and murine cSVD: impact of acute and chronic hypertensive states	17
Imaging features and consideration of progression pattern of diffuse hemispheric gliomas, H3 G34-mutant	17
Distinct forebrain regions define a dichotomous astrocytic profile in multiple system atrophy	17
Targeting NAD + biosynthesis suppresses TGF-β1/Smads/RAB26 axis and potentiates cisplatin cytotoxicity in non-small cell lung cancer brain metastasis	17

Inhibition of acid sphingomyelinase reduces reactive astrocyte secretion of mitotoxic extracellular vesicles and improves Alzheimer’s disease pathology in the 5xFAD mouse	17
Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model	17
Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease	17
Progesterone receptor distribution in the human hypothalamus and its association with suicide	17
Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells	16
Synergistic antitumor effect of temozolomide and perampanel in pediatric glioma: a case report and in vitro validation using patient-derived glioma sphere cells	16
Operationalizing postmortem pathology-MRI association studies in Alzheimer’s disease and related disorders with MRI-guided histology sampling	16
Cortical microvascular raspberries and ageing: an independent but not exclusive relationship	16
Tau seeding activity in various regions of down syndrome brain assessed by two novel assays	16
DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment	16
Investigating genotype-phenotype correlation of limb-girdle muscular dystrophy R8: association of clinical severity, protein biological function and protein oligomerization	16
Single-nucleus multi-omics of Parkinson’s disease reveals a glutamatergic neuronal subtype susceptible to gene dysregulation via alteration of transcriptional networks	16
Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered	16
Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!	16
A patient-derived cell model for malignant transformation in IDH-mutant glioma	16
Expanding clinicopathologic knowledge in high-grade glioma with pleomorphic and pseudopapillary features (HPAP): a report of two cases	16
BCKDK loss impairs mitochondrial Complex I activity and drives alpha-synuclein aggregation in models of Parkinson’s disease	16
ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer’s disease	16
Brain and circulating EV proteome signatures in schizophrenia as prognostic markers for age-related dementia	16
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease	15
Rab7a is required to degrade select blood-brain barrier junctional proteins after ischemic stroke	15
Muscle transcriptome profiling reveals novel molecular pathways and biomarkers in laminin-α2 deficient patients	15
Timing of microglial ablation determines protection from tau-mediated neurodegeneration and cognitive decline	15
TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis	15
Cryo-EM studies of amyloid-β fibrils from human and murine brains carrying the Uppsala APP mutation (Δ690–695)	15
Severe ACTA1-related nemaline myopathy: intranuclear rods, cytoplasmic bodies, and enlarged perinuclear space as characteristic pathological features on muscle biopsies	15
Transcription factor-based classification of pituitary adenomas / PitNETs: a comparative analysis and clinical implications across WHO 2004, 2017 and 2022 in 921 cases	15
Disordered DNA methylation leads to targetable transcriptional plasticity in ATRT	15
Trem2-deficiency aggravates and accelerates age-related myelin degeneration	15
Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis	15
The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease	15
Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue	15
TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice	15
Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain	15
The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation	15
Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease	15
The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration	15
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition	15
DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma	15
Quantitative multiplex immunohistochemistry with colorimetric staining (QUIVER) may still benefit from MILAN	14
High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy	14
On the origin and development of glioblastoma: multifaceted role of perivascular mesenchymal stromal cells	14
Amygdala granular fuzzy astrocytes are independently associated with both LATE neuropathologic change and argyrophilic grains: a study of Japanese series with a low to moderate Braak stage	14
Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic	14
Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer’s disease mouse model	14
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice	14
Correction: Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas	14
Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing	14
Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease	14
RNF168 dephosphorylation ameliorates cognitive decline in Aβ-based mouse models of Alzheimer’s disease	14
Traumatic brain injury induces TDP-43 mislocalization and neurodegenerative effects in tissue distal to the primary injury site in a non-transgenic mouse	14
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion	14
Correction: The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes	14
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling	14
Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A	14
Wolfram syndrome 1b mutation suppresses Mauthner-cell axon regeneration via ER stress signal pathway	14
Beyond the brain: early autonomic dysfunction in Alzheimer’s disease	14
Rapid intraoperative boundary diagnosis of somatotroph pituitary neuroendocrine tumors using real-time PCR	14
Plasma proteome profiling identifies changes associated to AD but not to FTD	13
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort	13
The role of plasminogen activator inhibitor-2 in pneumococcal meningitis	13
Publisher Correction: Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development an	13
A mouse model of stereotactic radiosurgery-induced neuroinflammation and blood-brain barrier compromise	13
Correction to: Dynamic profiling of medulloblastoma surfaceome	13
Running exercise mitigates amyloidosis in 5xFAD mice by improving the structure and function of the meningeal lymphatic system	13
CNS embryonal tumour with concomitant novel BRD4::CTRC1 fusion and BCOR internal tandem duplication – evidence for synergism and non-mutually exclusive alterations in CNS embryonal tumours	13
Disruption of mitochondrial homeostasis and permeability transition pore opening in OPA1 iPSC-derived retinal ganglion cells	13
Novel insights into meningioma brain invasion with spatial transcriptomic profiling	13
Lack of junctional adhesion molecule (JAM)-B traps CD8 T cells in CNS border zones and ameliorates autoimmune neuroinflammation	13
Alcohol-induced damage to the fimbria/fornix reduces hippocampal-prefrontal cortex connection during early abstinence	13
Presymptomatic pharmacological inhibition of mGluR5 improves survival in a mouse model of prion diseases	13
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators	13
Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies	13
Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer’s disease and experimental chronic cerebral hypoperfusion	13
PRC2 disruption in cerebellar progenitors produces cerebellar hypoplasia and aberrant myoid differentiation without blocking medulloblastoma growth	13
Clinicopathologic, molecular and tumor immune microenvironment features of mismatch repair-deficient glioblastomas in Lynch syndrome: a multicenter study of 29 cases with therapeutic implications	13
EZHIP boosts neuronal-like synaptic gene programs and depresses polyamine metabolism	13
LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease	13
Acquired neuropathology and its associations with key patterns of placental pathology	13
The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias	13
Brain macrophages and pial fibroblasts promote inflammation in a hypomyelination model	13
Cerebrovascular p16INK4A expression induces cerebral small vessel disease-related phenotypes	13